QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitor...
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
About this item
Full title
Author / Creator
Ghatalia, P , Je, Y , Kaymakcalan, M D , Sonpavde, G and Choueiri, T K
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background:
Multi-targeted vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs) are known to cause cardiac toxicity, but the relative risk (RR) of QTc interval prolongation and serious arrhythmias associated with them are not reported.
Methods:
We conducted a trial-level meta-analysis of randomised phase II...
Alternative Titles
Full title
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4453446
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4453446
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/bjc.2014.564
